First RFK Jr.-Era FDA Vaccine Ad Comm Sets Up Possible Policy Clash

By Jessica Karins / May 7, 2025 at 7:11 PM

FDA is set to hold what will doubtless be an unusually contentious advisory committee meeting May 22, when the Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene for the first time during the Trump administration, amid major turmoil over vaccine policy, to discuss COVID-19 booster shots for the 2025-26 respiratory virus season.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

First RFK Jr.-Era FDA Vaccine Ad Comm Sets Up Possible Policy Clash

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.